Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Peter J Arduini. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Peter J Arduini har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:GEHC / GE HealthCare Technologies Inc. | President and CEO, Director | 167 882 |
US:BMY / Bristol-Myers Squibb Company | Director | 38 266 |
US:GE / General Electric Company | Senior Vice President | 63 044 |
US:IART / Integra LifeSciences Holdings Corporation | President & CEO, Director | 0 |
US:BAX / Baxter International Inc. | Corporate Vice President | 76 800 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Peter J Arduini. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp IART / Integra LifeSciences Holdings Corporation - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i IART / Integra LifeSciences Holdings Corporation. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel IART / Integra LifeSciences Holdings Corporation - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i IART / Integra LifeSciences Holdings Corporation. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Peter J Arduini som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-03 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
F - Taxes | −5 472 | 167 882 | −3,16 | 73,73 | −403 451 | 12 377 940 | |
2025-09-03 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
F - Taxes | −5 874 | 173 354 | −3,28 | 73,73 | −433 090 | 12 781 390 | |
2025-03-05 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
A - Award | 41 931 | 179 228 | 30,54 | ||||
2025-03-04 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
F - Taxes | −29 818 | 137 297 | −17,84 | 87,35 | −2 604 602 | 11 992 893 | |
2025-03-04 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
F - Taxes | −4 507 | 167 115 | −2,63 | 87,35 | −393 686 | 14 597 495 | |
2025-02-10 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
A - Award | 67 487 | 171 622 | 64,81 | ||||
2025-02-04 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
F - Taxes | −3 206 | 104 135 | −2,99 | 88,30 | −283 090 | 9 195 120 | |
2024-09-04 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
F - Taxes | −5 859 | 107 341 | −5,18 | 84,82 | −496 960 | 9 104 664 | |
2024-03-05 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
A - Award | 36 399 | 113 200 | 47,39 | ||||
2024-03-05 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
F - Taxes | −4 444 | 76 801 | −5,47 | 91,28 | −405 648 | 7 010 395 | |
2023-03-03 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
A - Award | 39 425 | 81 245 | 94,27 | ||||
2023-02-03 |
|
4 | GEHC |
GE HealthCare Technologies Inc.
Common Stock, par value $0.01 per share |
A - Award | 21 425 | 41 820 | 105,05 | ||||
2022-04-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 462 | 38 266 | 1,22 | 73,03 | 33 750 | 2 794 574 | |
2022-03-03 |
|
4 | GE |
GENERAL ELECTRIC CO
Employee Stock Option (right to buy) |
A - Award | 63 044 | 63 044 | |||||
2022-03-03 |
|
4 | GE |
GENERAL ELECTRIC CO
Restricted Stock Units |
A - Award | 14 443 | 14 443 | |||||
2022-02-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 3 068 | 37 804 | 8,83 | 65,19 | 200 000 | 2 464 441 | |
2022-01-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 521 | 34 451 | 1,54 | 62,35 | 32 500 | 2 147 998 | |
2021-10-01 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 549 | 33 648 | 1,66 | ||||
2021-09-07 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −46 605 | 0 | −100,00 | |||
2021-09-07 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | −46 605 | 216 713 | −17,70 | 75,75 | −3 530 459 | 16 416 617 |
2021-09-07 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 46 605 | 263 318 | 21,51 | 20,88 | 973 112 | 5 498 080 |
2021-09-07 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −71 829 | 46 605 | −60,65 | |||
2021-09-07 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | −71 829 | 216 713 | −24,89 | 75,97 | −5 456 662 | 16 463 123 |
2021-09-07 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 71 829 | 288 542 | 33,14 | 20,88 | 1 499 790 | 6 024 757 |
2021-07-01 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 507 | 32 862 | 1,57 | ||||
2021-04-02 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 574 | 32 112 | 1,82 | 63,13 | 36 250 | 2 027 207 | |
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units |
M - Exercise | −368 | 552 716 | −0,07 | 68,10 | −25 061 | 37 639 960 | |
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units |
M - Exercise | −272 | 553 084 | −0,05 | 68,10 | −18 523 | 37 665 020 | |
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units |
M - Exercise | −258 | 553 356 | −0,05 | 68,10 | −17 570 | 37 683 544 | |
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −368 | 216 713 | −0,17 | 68,10 | −25 061 | 14 758 155 | |
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 368 | 217 081 | 0,17 | ||||
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −272 | 216 713 | −0,13 | 68,10 | −18 523 | 14 758 155 | |
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 272 | 216 985 | 0,13 | ||||
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −258 | 216 713 | −0,12 | 68,10 | −17 570 | 14 758 155 | |
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 258 | 216 971 | 0,12 | ||||
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units |
A - Award | 22 027 | 553 614 | 4,14 | ||||
2021-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 66 402 | 66 402 | |||||
2021-02-03 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −22 786 | 0 | −100,00 | |||
2021-02-03 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | −22 786 | 216 713 | −9,51 | 66,16 | −1 507 442 | 14 336 974 |
2021-02-03 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 22 786 | 239 499 | 10,51 | 15,79 | 359 791 | 3 781 689 |
2021-02-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 3 054 | 31 537 | 10,72 | 62,21 | 190 000 | 1 961 943 | |
2021-01-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 584 | 28 261 | 2,11 | 62,03 | 36 250 | 1 753 008 | |
2020-12-21 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −45 000 | 22 786 | −66,39 | |||
2020-12-21 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | −45 000 | 216 713 | −17,19 | 61,97 | −2 788 780 | 13 430 333 |
2020-12-21 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 45 000 | 261 713 | 20,76 | 15,79 | 710 550 | 4 132 448 |
2020-10-02 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 601 | 27 468 | 2,24 | 60,29 | 36 250 | 1 656 075 | |
2020-07-02 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 616 | 26 664 | 2,37 | 58,80 | 36 250 | 1 567 854 | |
2020-04-02 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 650 | 25 855 | 2,58 | 55,74 | 36 250 | 1 441 137 | |
2020-03-27 |
|
4/A | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units |
A - Award | 27 657 | 531 587 | 5,49 | ||||
2020-03-27 |
|
4/A | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 138 143 | 138 143 | |||||
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units |
A - Award | 41 485 | 545 415 | 8,23 | ||||
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units |
M - Exercise | −272 | 503 930 | −0,05 | 43,39 | −11 802 | 21 865 523 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units |
M - Exercise | −258 | 504 202 | −0,05 | 43,39 | −11 195 | 21 877 325 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −290 | 504 460 | −0,06 | 43,39 | −12 583 | 21 888 519 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 92 096 | 92 096 | |||||
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −12 041 | 216 713 | −5,26 | 43,39 | −522 459 | 9 403 177 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −7 085 | 228 754 | −3,00 | 43,39 | −307 418 | 9 925 636 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −6 736 | 235 839 | −2,78 | 43,39 | −292 275 | 10 233 054 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −272 | 242 575 | −0,11 | 43,39 | −11 802 | 10 525 329 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 272 | 242 847 | 0,11 | ||||
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −258 | 242 575 | −0,11 | 43,39 | −11 195 | 10 525 329 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 258 | 242 833 | 0,11 | ||||
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −290 | 242 575 | −0,12 | 43,39 | −12 583 | 10 525 329 | |
2020-03-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 290 | 242 865 | 0,12 | ||||
2020-02-28 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −32 316 | 0 | −100,00 | |||
2020-02-28 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | −32 316 | 242 575 | −11,76 | 55,68 | −1 799 332 | 13 506 406 |
2020-02-28 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 32 316 | 274 891 | 13,32 | 13,89 | 448 869 | 3 818 236 |
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 540 | 32 316 | −9,87 | |||
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −21 960 | 35 856 | −37,98 | |||
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | −3 540 | 242 575 | −1,44 | 57,12 | −202 190 | 13 854 889 |
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 3 540 | 246 115 | 1,46 | 13,89 | 49 171 | 3 418 537 |
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | −21 960 | 242 575 | −8,30 | 57,12 | −1 254 265 | 13 854 889 |
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 21 960 | 264 535 | 9,05 | 13,89 | 305 024 | 3 674 391 |
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −37 704 | 57 816 | −39,47 | |||
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | −37 704 | 242 575 | −13,45 | 58,21 | −2 194 923 | 14 121 407 |
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 37 704 | 280 279 | 15,54 | 13,89 | 523 709 | 3 893 075 |
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −20 344 | 95 520 | −17,56 | |||
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | −20 344 | 242 575 | −7,74 | 59,56 | −1 211 729 | 14 448 252 |
2020-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 20 344 | 262 919 | 8,39 | 13,89 | 282 578 | 3 651 945 |
2020-02-18 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 16 316 | 242 575 | 7,21 | ||||
2020-02-18 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 15 512 | 226 259 | 7,36 | ||||
2020-02-18 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 27 730 | 210 747 | 15,15 | ||||
2020-02-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 3 018 | 25 204 | 13,60 | 62,95 | 190 000 | 1 586 610 | |
2020-01-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 565 | 22 030 | 2,63 | 64,19 | 36 250 | 1 414 112 | |
2019-10-02 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 715 | 21 312 | 3,47 | 50,71 | 36 250 | 1 080 757 | |
2019-09-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −250 000 | 115 864 | −68,33 | |||
2019-09-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | −250 000 | 183 017 | −57,73 | 60,55 | −15 137 150 | 11 081 423 |
2019-09-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 250 000 | 433 017 | 136,60 | 13,89 | 3 472 500 | 6 014 606 |
2019-07-02 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 768 | 20 412 | 3,91 | 45,35 | 34 808 | 925 707 | |
2019-04-02 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 681 | 19 474 | 3,62 | 47,71 | 32 500 | 929 083 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −368 | 504 750 | −0,07 | 56,14 | −20 660 | 28 336 665 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −15 292 | 183 017 | −7,71 | 56,14 | −858 493 | 10 274 574 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −368 | 198 309 | −0,19 | 56,14 | −20 660 | 11 133 067 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 368 | 198 677 | 0,19 | ||||
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
A - Award | 20 390 | 505 118 | 4,21 | ||||
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −258 | 484 728 | −0,05 | 55,91 | −14 425 | 27 101 142 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −290 | 484 986 | −0,06 | 55,91 | −16 214 | 27 115 567 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 91 249 | 91 249 | |||||
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −11 687 | 198 309 | −5,57 | 55,91 | −653 420 | 11 087 456 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −6 215 | 209 996 | −2,87 | 55,91 | −347 481 | 11 740 876 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −258 | 216 211 | −0,12 | 55,91 | −14 425 | 12 088 357 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 258 | 216 469 | 0,12 | ||||
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −290 | 216 211 | −0,13 | 55,91 | −16 214 | 12 088 357 | |
2019-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 290 | 216 501 | 0,13 | ||||
2019-02-19 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 14 312 | 216 211 | 7,09 | ||||
2019-02-19 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 26 914 | 201 899 | 15,38 | ||||
2019-02-19 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 35 217 | 174 985 | 25,20 | ||||
2019-02-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 3 708 | 18 792 | 24,58 | 49,89 | 185 000 | 937 550 | |
2019-01-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 625 | 14 761 | 4,42 | 51,98 | 32 500 | 767 264 | |
2018-10-02 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 524 | 14 136 | 3,85 | 62,08 | 32 500 | 877 533 | |
2018-07-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 587 | 13 612 | 4,51 | 55,34 | 32 500 | 753 288 | |
2018-04-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 514 | 12 927 | 4,14 | 63,25 | 32 500 | 817 606 | |
2018-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −343 | 485 276 | −0,07 | 54,15 | −18 573 | 26 277 695 | |
2018-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −10 994 | 139 768 | −7,29 | 54,15 | −595 325 | 7 568 437 | |
2018-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −343 | 150 762 | −0,23 | 54,15 | −18 573 | 8 163 762 | |
2018-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 343 | 151 105 | 0,23 | ||||
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −368 | 485 619 | −0,08 | 56,14 | −20 660 | 27 262 651 | |
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −368 | 150 762 | −0,24 | 56,14 | −20 660 | 8 463 779 | |
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 368 | 151 130 | 0,24 | ||||
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −14 842 | 150 762 | −8,96 | 56,14 | −833 230 | 8 463 779 | |
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −290 | 485 987 | −0,06 | 56,23 | −16 307 | 27 327 049 | |
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
A - Award | 19 385 | 486 277 | 4,15 | ||||
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 75 069 | 75 069 | |||||
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −290 | 165 604 | −0,17 | 56,23 | −16 307 | 9 311 913 | |
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 290 | 165 894 | 0,18 | ||||
2018-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −11 687 | 165 604 | −6,59 | 56,23 | −657 160 | 9 311 913 | |
2018-02-20 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 26 914 | 177 291 | 17,90 | ||||
2018-02-20 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 34 182 | 150 377 | 29,42 | ||||
2018-02-20 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 25 318 | 116 195 | 27,86 | ||||
2018-02-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 2 946 | 12 413 | 31,12 | 62,80 | 185 000 | 779 521 | |
2018-01-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 530 | 9 407 | 5,97 | 61,28 | 32 500 | 576 459 | |
2017-10-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 510 | 8 821 | 6,13 | 63,74 | 32 500 | 562 268 | |
2017-07-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 560 | 8 254 | 7,28 | 55,72 | 31 223 | 459 912 | |
2017-04-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 529 | 7 641 | 7,43 | 54,38 | 28 750 | 415 503 | |
2017-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −413 | 466 892 | −0,09 | 42,74 | −17 652 | 19 954 964 | |
2017-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −413 | 90 877 | −0,45 | 42,74 | −17 652 | 3 884 083 | |
2017-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 413 | 91 290 | 0,45 | ||||
2017-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −13 640 | 90 877 | −13,05 | 42,74 | −582 974 | 3 884 083 | |
2017-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −353 | 467 305 | −0,08 | 42,35 | −14 950 | 19 790 367 | |
2017-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −353 | 104 517 | −0,34 | 42,35 | −14 950 | 4 426 295 | |
2017-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 353 | 104 870 | 0,34 | ||||
2017-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −11 308 | 104 517 | −9,76 | 42,35 | −478 894 | 4 426 295 | |
2017-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −378 | 467 658 | −0,08 | 43,03 | −16 265 | 20 123 324 | |
2017-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −378 | 115 825 | −0,33 | 43,03 | −16 265 | 4 983 950 | |
2017-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 378 | 116 203 | 0,33 | ||||
2017-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −15 730 | 115 825 | −11,96 | 43,03 | −676 862 | 4 983 950 | |
2017-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
A - Award | 21 750 | 468 036 | 4,87 | ||||
2017-03-15 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 84 071 | 84 071 | |||||
2017-03-01 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | −40 000 | 311 588 | −11,38 | ||||
2017-03-01 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | −40 000 | 131 555 | −23,32 | 42,28 | −1 691 224 | 5 562 224 |
2017-03-01 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 40 000 | 171 555 | 30,41 | 13,89 | 555 600 | 2 382 899 |
2017-03-01 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | −8 018 | 131 555 | −5,74 | 42,28 | −339 006 | 5 562 224 |
2017-02-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 34 179 | 139 573 | 32,43 | ||||
2017-02-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 24 570 | 105 394 | 30,40 | ||||
2017-02-17 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 29 638 | 80 824 | 57,90 | ||||
2017-02-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 3 449 | 7 112 | 94,16 | 49,29 | 170 000 | 350 552 | |
2017-01-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 492 | 3 634 | 15,66 | 58,44 | 28 750 | 212 389 | |
2016-11-09 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | −20 000 | 175 794 | −10,21 | ||||
2016-11-09 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | −20 000 | 25 593 | −43,87 | 80,02 | −1 600 302 | 2 047 826 |
2016-11-09 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 20 000 | 45 593 | 78,15 | 27,78 | 555 600 | 1 266 574 |
2016-11-09 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | −4 009 | 25 593 | −13,54 | 77,00 | −308 708 | 1 970 756 |
2016-10-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 533 | 3 119 | 20,62 | 53,92 | 28 750 | 168 178 | |
2016-08-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −12 009 | 195 794 | −5,78 | |||
2016-08-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | −12 009 | 29 602 | −28,86 | 84,65 | −1 016 557 | 2 505 797 |
2016-08-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 12 009 | 41 611 | 40,57 | 27,78 | 333 610 | 1 155 954 |
2016-08-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −7 991 | 207 803 | −3,70 | |||
2016-08-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | −7 991 | 29 602 | −21,26 | 84,19 | −672 757 | 2 492 175 |
2016-08-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | X | 7 991 | 37 593 | 26,99 | 27,78 | 221 990 | 1 044 334 |
2016-08-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
S - Sale | X | −4 009 | 29 602 | −11,93 | 84,77 | −339 837 | 2 509 320 |
2016-07-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 373 | 2 573 | 16,95 | 73,55 | 27 431 | 189 243 | |
2016-04-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Deferred Share Units |
A - Award | 2 188 | 2 188 | |||||
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −105 | 223 143 | −0,05 | 64,37 | −6 759 | 14 363 715 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Performance Stock |
M - Exercise | −607 | 21 182 | −2,79 | 64,37 | −39 073 | 1 363 485 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −4 605 | 33 611 | −12,05 | 64,37 | −296 424 | 2 163 540 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −607 | 38 216 | −1,56 | 64,37 | −39 073 | 2 459 964 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 607 | 38 823 | 1,59 | ||||
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −105 | 38 216 | −0,27 | 64,37 | −6 759 | 2 459 964 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 105 | 38 321 | 0,27 | ||||
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −207 | 223 248 | −0,09 | 64,37 | −13 325 | 14 370 474 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −6 476 | 38 216 | −14,49 | 64,37 | −416 860 | 2 459 964 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −207 | 44 692 | −0,46 | 64,37 | −13 325 | 2 876 824 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 207 | 44 899 | 0,46 | ||||
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −177 | 223 455 | −0,08 | 64,81 | −11 471 | 14 482 119 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −177 | 44 692 | −0,39 | 64,81 | −11 471 | 2 896 489 | |
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 177 | 44 869 | 0,40 | ||||
2016-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −5 531 | 44 692 | −11,01 | 64,81 | −358 464 | 2 896 489 | |
2016-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
A - Award | 13 811 | 223 632 | 6,58 | ||||
2016-03-16 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 64 625 | 64 625 | |||||
2016-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Performance Stock |
A - Award | 14 800 | 21 789 | 211,76 | ||||
2016-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 12 285 | 50 223 | 32,38 | ||||
2016-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 14 384 | 37 938 | 61,07 | ||||
2016-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 6 783 | 23 554 | 40,44 | ||||
2015-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −105 | 209 821 | −0,05 | 61,58 | −6 466 | 12 920 777 | |
2015-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Performance Stock |
M - Exercise | −259 | 6 047 | −4,11 | 61,58 | −15 949 | 372 374 | |
2015-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −1 302 | 16 307 | −7,39 | 61,58 | −80 177 | 1 004 185 | |
2015-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −259 | 17 609 | −1,45 | 61,58 | −15 949 | 1 084 362 | |
2015-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | −259 | 17 868 | −1,43 | ||||
2015-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −105 | 17 609 | −0,59 | 61,58 | −6 466 | 1 084 362 | |
2015-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 105 | 17 714 | 0,60 | ||||
2015-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −207 | 209 926 | −0,10 | 62,65 | −12 969 | 13 151 864 | |
2015-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −5 603 | 17 609 | −24,14 | 62,65 | −351 028 | 1 103 204 | |
2015-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −207 | 23 212 | −0,88 | 62,65 | −12 969 | 1 454 232 | |
2015-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 207 | 23 419 | 0,89 | ||||
2015-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
A - Award | 12 883 | 210 133 | 6,53 | ||||
2015-03-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 59 791 | 59 791 | |||||
2015-02-23 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −248 | 197 250 | −0,13 | 56,99 | −14 134 | 11 241 278 | |
2015-02-23 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −248 | 23 212 | −1,06 | 56,99 | −14 134 | 1 322 852 | |
2015-02-23 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 248 | 23 460 | 1,07 | ||||
2015-02-19 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Performance Stock |
A - Award | 6 306 | 6 306 | |||||
2015-02-19 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 12 444 | 23 212 | 115,56 | ||||
2015-02-19 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 2 890 | 10 768 | 36,68 | ||||
2015-01-06 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −1 390 | 197 498 | −0,70 | ||||
2015-01-06 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −1 390 | 7 878 | −15,00 | 53,39 | −74 212 | 420 606 | |
2015-01-06 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 1 390 | 9 268 | 17,64 | ||||
2014-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units (Contract Stock) |
M - Exercise | −84 | 198 888 | −0,04 | 45,77 | −3 845 | 9 103 104 | |
2014-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −84 | 7 878 | −1,06 | 45,77 | −3 845 | 360 576 | |
2014-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 84 | 7 962 | 1,07 | ||||
2014-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −880 | 7 878 | −10,05 | 45,77 | −40 278 | 360 576 | |
2014-03-26 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units (Contract Stock) |
A - Award | 15 083 | 198 972 | 8,20 | ||||
2014-03-10 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 56 727 | 56 727 | |||||
2014-02-24 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −248 | 183 889 | −0,13 | 47,37 | −11 748 | 8 710 822 | |
2014-02-24 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −248 | 8 758 | −2,75 | 47,37 | −11 748 | 414 866 | |
2014-02-24 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 248 | 9 006 | 2,83 | ||||
2014-01-06 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −1 401 | 184 137 | −0,76 | ||||
2014-01-06 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −1 401 | 8 758 | −13,79 | 47,81 | −66 982 | 418 720 | |
2014-01-06 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 1 401 | 10 159 | 16,00 | ||||
2013-05-24 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 32 468 | 32 468 | |||||
2013-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
A - Award | 7 644 | 185 538 | 4,30 | ||||
2013-03-27 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
A - Award | 8 758 | 8 758 | |||||
2013-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −248 | 177 894 | −0,14 | 40,34 | −10 004 | 7 176 244 | |
2013-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −149 | 178 142 | −0,08 | 40,34 | −6 011 | 7 186 248 | |
2013-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −397 | 0 | −100,00 | 40,34 | −16 015 | ||
2013-02-25 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 397 | 397 | |||||
2013-01-04 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
M - Exercise | −1 423 | 178 291 | −0,79 | ||||
2013-01-04 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −1 423 | 0 | −100,00 | 39,54 | −56 265 | ||
2013-01-04 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 1 423 | 1 423 | |||||
2012-03-05 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 25 997 | 232 716 | 12,58 | ||||
2012-03-05 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 206 719 | 206 719 | |||||
2012-02-23 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units (contract stock) |
A - Award | 4 537 | 179 714 | 2,59 | ||||
2012-02-23 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units (contract stock) |
A - Award | 22 684 | 175 177 | 14,88 | ||||
2012-01-04 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units/Contract Stock |
A - Award | 118 363 | 152 493 | 346,80 | ||||
2010-11-03 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units (Contract Stock) |
M - Exercise | −738 | 34 130 | −2,12 | ||||
2010-11-03 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Restricted Stock Units (Contract Stock) |
A - Award | 34 868 | 34 868 | |||||
2010-11-03 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
F - Taxes | −738 | 0 | −100,00 | 43,02 | −31 749 | ||
2010-11-03 |
|
4 | IART |
INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock |
M - Exercise | 738 | 738 | |||||
2007-03-16 |
|
4 | BAX |
BAXTER INTERNATIONAL INC
Stock Option (Right to Buy) |
A - Award | 76 800 | 76 800 | |||||
2007-03-16 |
|
4 | BAX |
BAXTER INTERNATIONAL INC
Common Stock, $1 par value |
A - Award | 8 700 | 49 767 | 21,18 | ||||
2007-03-16 |
|
4 | BAX |
BAXTER INTERNATIONAL INC
Common Stock, $1 par value |
F - Taxes | −2 106 | 41 067 | −4,88 | 50,74 | −106 858 | 2 083 740 | |
2006-03-16 |
|
4 | BAX |
BAXTER INTERNATIONAL INC
Stock Option (Right to Buy) |
A - Award | 132 000 | 132 000 | |||||
2006-03-16 |
|
4 | BAX |
BAXTER INTERNATIONAL INC
Common Stock, $1 par value |
A - Award | 21 450 | 44 450 | 93,26 | ||||
2005-04-19 | 3 | BAX |
BAXTER INTERNATIONAL INC
Common Stock, $1 par value |
0 |